Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ALS ( (AU:ALQ) ) has provided an update.
ALS Limited has announced the application for quotation of 20,958,084 ordinary fully paid securities on the Australian Securities Exchange (ASX), scheduled for issue on June 2, 2025. This move is part of previously announced transactions and reflects the company’s ongoing efforts to enhance its market presence and operational capacity, potentially impacting its stakeholders by increasing the liquidity and accessibility of its shares.
The most recent analyst rating on (AU:ALQ) stock is a Buy with a A$15.20 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.
More about ALS
ALS Limited operates in the testing, inspection, and certification industry, providing analytical and laboratory services across various sectors including minerals, life sciences, energy, and industrials. The company is known for its comprehensive range of testing services that support quality assurance and regulatory compliance for its clients worldwide.
Average Trading Volume: 1,252,132
Technical Sentiment Signal: Buy
Current Market Cap: A$8.55B
For a thorough assessment of ALQ stock, go to TipRanks’ Stock Analysis page.

